drugset / Trial / NCT00125528

D-cycloserine in the Management of Chronic Low Back Pain

NCT00125528

Phase 2 Completed 41 enrolled Thomas J. Schnitzer
RandomizedParallel-groupTriple-blindTreatment

Summary

Pre-clinical studies in rats suggest that D-cycloserine (DCS) is effective in the management of chronic neuropathic pain. This pilot study will attempt to determine the effect of D-cycloserine in the treatment of chronic low back pain. Other aims of this study are to determine the safety of D-cycloserine in the treatment of chronic low back pain and to determine which pain measurement scales are best at measuring the efficacy of treatment.

Timeline

Start
2012-07
Primary completion
2014-04
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 200 mg Oral

Indications

No indication recorded.